HI
UTMD icon

Harbour Investments’s Utah Medical Products UTMD Stock Holding History

Harbour Investments’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-78
Closed -$4.91K – 4024
2025
Q3 		$4.91K Hold
78
– – ﹤0.01% 2996
2025
Q2 		$4.44K Hold
78
– – ﹤0.01% 2924
2025
Q1 		$4.37K Hold
78
– – ﹤0.01% 2871
2024
Q4 		$4.79K Hold
78
– – ﹤0.01% 2736
2024
Q3 		$5.22K Buy
+78
New +$5.29K ﹤0.01% 2613

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harbour Investments's UTMD Position: Q4 2025 in Review

Harbour Investments sold out of Utah Medical Products (UTMD) in Q4 2025, closing a stake of 78 shares — an estimated $4.91K sold.

Harbour Investments first reported a position in UTMD in Q3 2024 and held it in 5 quarters. The position peaked at $5.22K in Q3 2024. 117 funds tracked by Wall St. Rank hold UTMD as of Q4 2025.

  • Harbour Investments reported no remaining Utah Medical Products position as of Q4 2025 after selling out during the quarter.
  • Harbour Investments sold 78 Utah Medical Products shares in Q4 2025, an estimated $4.91K.
  • Harbour Investments first reported a position in Utah Medical Products in Q3 2024 and held it in 5 quarters.
  • Harbour Investments's Utah Medical Products position peaked at $5.22K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2025.

Based on Harbour Investments's 13F filing for Q4 2025, filed 9 Feb 2026.